GlobeNewswire·Nov 12, 2026, 8:30 AM ET

Nortech Systems Reports Third Quarter Results

Nortech Systems reported Q3 2026 net sales of $33.0 million, an 8.4% increase from $30.5 million in Q3 2025.
Net income for Q3 2026 was $637 thousand ($0.21 per diluted share), compared to a net loss of $146 thousand in Q3 2025.
Adjusted EBITDA for Q3 2026 reached $2.0 million, up from $1.3 million in the same period last year.
Total backlog stood at $92.8 million as of September 30, 2026, representing a 20% increase from the prior year.
The 90-day backlog was $31.5 million as of September 30, 2026, slightly up from $31.3 million in 2025.
Year-to-date net sales for the nine months ended September 30, 2026, totaled $96.9 million, a 10.1% increase from $88.1 million in 2025.
Gross profit for Q3 2026 was $5.9 million, reflecting a 16.9% improvement over Q3 2025.
China operations drove significant growth with net sales increasing more than 56% in the quarter.
CFO Andrew D. C. LaFrence will join CEO Jay D. Miller for a conference call on November 12, 2026, to discuss the results.
Restructuring charges were $0 in Q3 2026, while $236 thousand in strategy review expenses were recorded as non-GAAP adjustments.
Cash and restricted cash increased to $4.1 million as of September 30, 2026, from $1.3 million in the prior year period.
The company serves medical imaging, medical device, industrial, aerospace, defense markets with manufacturing locations in the U.S., Mexico, China.

Company: Nortech Systems Incorporated
Keywords: Nasdaq:NSYS, Nortech Systems Incorporated, Nortech Systems Incorporated, Nasdaq: NSYS, Third Quarter Results, complex electromedical, electromechanical products